Published

Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: European Neuropsychopharmacology
Date: 2018-12-31
Source: OpenAlex
DOI: 10.1016/j.euroneuro.2018.11.474
PubMed: Unavailable

Authors

M. Madsen Daniel Burmester Dea Siggaard Stenbæk Søren Kristiansen Agnete Dyssegaard Szabolcs Lehel Kristían Línnet Sys Stybe Johansen Claus Svarer Brice Ozenne David Erritzøe Patrick M. Fisher Gitte M. Knudsen

Watch author

Topics and keywords

psilocybin psilocin Receptor Pharmacology Other Visual analogue scale Medicine Recall Analysis of variance Orthopedic surgery Anesthesia Physical therapy Surgery Psychology Internal medicine Cognitive psychology Psychedelics and Drug Studies Neurotransmitter Receptor Influence on Behavior Chemical synthesis and alkaloids

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans2018-12-31

Related papers

Psilocybin therapy: A novel approach to treating depressionInternational Journal of Surgery Global Health · 2023-06-01 Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine and Surgery · 2026-06-17 Advancing treatment paradigms: the role of psilocybin in managing major depressive disorderAnnals of Medicine and Surgery · 2025-11-23 The psychedelic renaissance: can psilocybin possibly combat depression?International Journal of Surgery Global Health · 2022-10-31